Every ten seconds, someone dies of diabetes-related causes
United Nations Day increases awareness of the causes and risks associated with this
Leverkusen, November 14, 2007 – Regarded as one of the main risk factors for myo-
cardial infarction and strokes, diabetes is among the most common causes of death
worldwide. Someone dies from the consequences of this metabolic disorder every ten
seconds. According to the latest estimates by the International Diabetes Federation (IDF),
approximately 246 million people are currently living with this disease – six percent of the
world’s adult population. The organization expects this number to grow to 380 million by
2025 unless appropriate countermeasures are taken. Therefore, the metabolic disorder is
supposed to be one of the greatest health threats of humanity. Its effects are already
clearly noticeable: the cost of treating diabetes and its complications has risen dramati-
cally in recent years and threatens to undermine economic prosperity in many countries,
especially those with weak economies.
Together with other leading health and patient organizations, the IDF formed a global
coalition in June 2006 and launched the “Unite for Diabetes” awareness campaign. It
seeks to raise awareness of the metabolic disorder and encourage policy-makers to en-
sure provision of better preventive measures and therapeutic options in order to effec-
tively curb the worldwide rise in the prevalence of this disease.
The IDF and its partners were able to celebrate an initial success in December 2006
when the General Assembly of the United Nations in New York passed a resolution on
diabetes for the first time in its history. The draft was sponsored by Bangladesh and
unanimously approved. In this resolution, the 192 Member States for the first time
acknowledged the serious global threat and challenge posed by a non-infectious disease
- 1/3 -
and placed this chronic metabolic disorder on a level with HIV/AIDS, tuberculosis, and
In order to generate additional support for the resolution and to encourage the govern-
ments of the Member States to implement the recommendations in concrete action as
quickly as possible, the United Nations has officially designated World Diabetes Day on
November 14 as a United Nations Day for the first time this year.
About World Diabetes Day
World Diabetes Day has been celebrated on November 14 every year since 1991 in more
than 150 countries around the world, with numerous activities ranging from radio broad-
casts through sporting events and marches all the way to educational campaigns. In col-
laboration with the World Health Organization (WHO), the IDF selects a different central
theme each year. The focus in 2007 is on “Diabetes in Children and Adolescents.” The
goal is to increase public awareness of the causes and symptoms, prevention and treat-
ment options as well as complications associated with this chronic metabolic disorder. In
addition, attention is called to the drastic increase in the number of cases of this disease
More information can be found at www.bayerdiabetes.com, www.idf.org and
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading innovative
companies in the health care and medical products industry.
The company combines the activities of the Animal Health, Consumer Care, Diabetes
Care, Diagnostics and Pharmaceuticals divisions. The company's pharmaceuticals busi-
ness operates under the name Bayer Schering Pharma AG.
Bayer HealthCare’s aim is to discover, develop, manufacture and market products that
will improve human and animal health worldwide.
Dr. Gisela Lenz, Phone: +49 (0)214 30 -58030, Fax: +49 (0) 214 30-56723
- 2/3 -
Just a click away – our online press service: www.viva.vita.bayerhealthcare.com
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer
Group management. Various known and unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation, development or performance of the company and the
estimates given here. These factors include those discussed in our annual and interim reports to the Frankfurt Stock
Exchange and in our reports filed with the U.S. Securities and Exchange Commission (including our Form 20-F). The
company assumes no liability whatsoever to update these forward-looking statements or to conform them to future
events or developments.
- 3/3 -